Printer Friendly

R.P. SCHERER ANNOUNCES ACQUISITION IN SPAIN

 TROY, Mich., Sept. 1 /PRNewswire/ -- R.P. Scherer Corporation (NYSE: SHR) and Wellcome plc (NYSE: WEL) announce that R.P. Scherer G.m.b.H., Eberbach, Germany, has acquired the assets and rights from Gayoso Wellcome S.A. for the commercialization of softgels in Spain and Portugal.
 Gayoso Wellcome is a wholly owned subsidiary of Wellcome plc and has been in the softgel business in Spain for 25 years. R.P. Scherer G.m.b.H. is the 51-percent owned German subsidiary of R.P. Scherer Corporation.
 The transaction combines Scherer's technology and product know-how with Gayoso Wellcome's customer and market base, allowing R.P. Scherer G.m.b.H. to fully develop the potential of the Iberian market for soft gelatin capsule products.
 R.P. Scherer Corporation, an international developer and manufacturer of drug delivery systems, is the world's largest producer of soft gelatin capsules ("softgels"). The company is currently developing and commercializing advanced drug delivery systems, including SCHERERSOL(TM), ZYDIS(R) and PULSINCAP(TM) technologies. The company's proprietary drug delivery systems improve the efficacy of drugs by regulating the dosage, rate of absorption and place of release. The company operates a global network of 18 facilities in 11 countries.
 -0- 9/1/93
 /CONTACT: Nicole Williams, Executive VP & CFO of R.P. Scherer, 313-649-0900/
 (SHR WEL)


CO: R.P. Scherer Corporation; Wellcome plc; R.P. Scherer G.m.b.H;
 Gayoso Wellcome S.A. ST: Michigan IN: MTC SU: TNM


ML -- DE002 -- 7814 09/01/93 09:18 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 1, 1993
Words:251
Previous Article:ESSEX CORPORATION PREVAILS IN DOE CONTRACT PROTEST
Next Article:BARRETT RESOURCES COMPLETES SALE OF WATTENBERG FIELD INTERESTS
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters